Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | TMO | ZTS |
|---|
| Close | 648.43 | 73.00 |
| Market Cap | $240B | $31.9B |
| 1M | +10.75% | +0.04% |
| P/E (TTM) | 34.4 | 11.5 |
| Forward P/E | 21.8 | 10.6 |
| P/E 5-Yr Percentile | 65 | 0 |
| P/S | 5.2 | 3.2 |
| P/B | 4.6 | 9.6 |
| Dividend Yield | 0.29% | 1.64% |
| Latest Quarter Revenue | $12.0B | $2.5B |
| Revenue YoY | +10.5% | −0.2% |
| Gross Margin | — | 72.7% |
| Latest Quarter EPS | 4.68 | 1.65 |
| Avg Post-Earnings Move | ±1.2% | ±3.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.36% | 11.43% |
| 90-Day Net Insider Buying | −$38.9M | — |
TMO · Revenue, Last 8 Quarters ($B)
ZTS · Revenue, Last 8 Quarters ($B)
